181 related articles for article (PubMed ID: 35631431)
1. Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response.
Ling C; Zhou X; Gao Y; Sui X
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631431
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Wang Q; Li M; Yang M; Yang Y; Song F; Zhang W; Li X; Chen K
Aging (Albany NY); 2020 Feb; 12(4):3312-3339. PubMed ID: 32091408
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
4. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
[TBL] [Abstract][Full Text] [Related]
5. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
7. Towards Personalized Treatment Strategies for Esophageal Adenocarcinoma; A Review on the Molecular Characterization of Esophageal Adenocarcinoma and Current Research Efforts on Individualized Curative Treatment Regimens.
Hoefnagel SJM; Boonstra JJ; Russchen MJAM; Krishnadath KK
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638363
[TBL] [Abstract][Full Text] [Related]
8. Analysis of immune-related signatures of colorectal cancer identifying two different immune phenotypes: Evidence for immune checkpoint inhibitor therapy.
Chen G; Wang L; Diao T; Chen Y; Cao C; Zhang X
Oncol Lett; 2020 Jul; 20(1):517-524. PubMed ID: 32565977
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Immune-Related Multi-IncRNA Signatures Associated With Tumor Microenvironment in Esophageal Cancer.
Pang J; Pan H; Yang C; Meng P; Xie W; Li J; Li Y; Xiao SY
Front Genet; 2021; 12():722601. PubMed ID: 34659345
[TBL] [Abstract][Full Text] [Related]
10. An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma.
Yang C; Cao F; He Y
Med Sci Monit; 2023 Aug; 29():e940157. PubMed ID: 37632137
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
12. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
13. Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Carroll TM; Chadwick JA; Owen RP; White MJ; Kaplinsky J; Peneva I; Frangou A; Xie PF; Chang J; Roth A; Amess B; James SA; Rei M; Fuchs HS; McCann KJ; Omiyale AO; Jacobs BA; Lord SR; Norris-Bulpitt S; Dobbie ST; Griffiths L; Ramirez KA; Ricciardi T; Macri MJ; Ryan A; Venhaus RR; Van den Eynde BJ; Karydis I; Schuster-Böckler B; Middleton MR; Lu X;
Cancer Cell; 2023 Jul; 41(7):1222-1241.e7. PubMed ID: 37433281
[TBL] [Abstract][Full Text] [Related]
14. Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.
Guo X; Tang Y; Zhu W
BMC Genomics; 2018 Oct; 19(1):769. PubMed ID: 30355311
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
Jang HJ; Lee HS; Ramos D; Park IK; Kang CH; Burt BM; Kim YT
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1598-1610.e3. PubMed ID: 31879171
[TBL] [Abstract][Full Text] [Related]
16. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
18. Association of
Liu Z; Liu L; Jiao D; Guo C; Wang L; Li Z; Sun Z; Zhao Y; Han X
Front Genet; 2021; 12():669694. PubMed ID: 34079583
[No Abstract] [Full Text] [Related]
19. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy
Zhong W; Zhong H; Zhang F; Huang C; Lin Y; Huang J
Front Mol Biosci; 2021; 8():684050. PubMed ID: 34250018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
